모바일 헬스(mHealth) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)
mHealth Market (Product: Connected Medical Devices, mHealth Applications, and mHealth Services; and End-user: B2B and B2C) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
상품코드:1442872
리서치사:Transparency Market Research
발행일:2024년 01월
페이지 정보:영문 289 Pages
라이선스 & 가격 (부가세 별도)
한글목차
모바일 헬스(mHealth) 시장
세계의 모바일 헬스(mHealth) 시장에 관한 과거와 현재의 성장 동향 및 2023-2031년의 예측 기간 중 시장 지표의 귀중한 인사이트를 얻을 기회를 연구하고 있습니다. 2017-2031년 세계 모바일 헬스(mHealth) 시장의 매출을 제공합니다. 2023년을 기준년, 2031년을 예측년으로 간주하며, 2023-2031년의 세계 모바일 헬스(mHealth) 시장의 연평균 성장률(CAGR %)도 제공합니다.
광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서는 조사 활동의 대부분을 시행하고 애널리스트가 주요 오피니언 리더, 업계 리더, 오피니언 제조업체와 인터뷰를 진행했습니다. 2차 조사에는 모바일 헬스(mHealth) 시장을 이해하기 위해 주요 기업의 제품 문헌, 연차보고서, 프레스 릴리스 및 관련 문서의 참조가 포함됩니다.
이 리포트는 세계의 모바일 헬스(mHealth) 시장의 경쟁 구도를 자세하게 조사하고 있습니다. 세계의 모바일 헬스(mHealth) 시장에서 활동하는 주요 기업이 식별되고 각각의 기업이 다양한 속성의 관점에서 프로파일링되고 있습니다. 회사 개요, 재무 상황, 최근 동향, SWOT는 이 리포트에서 소개되고 있는 세계의 모바일 헬스(mHealth) 시장 기업의 속성입니다.
목차
제1장 주요 요약
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
시장 세분화
개요
시장 역학
세계 시장의 분석과 예측(2017-2031년)
제5장 주요 인사이트
파이프라인 분석
COVID-19 팬데믹이 업계에 미치는 영향
제6장 시장 분석과 예측 : 제품별
서론과 정의
주요 조사 결과/발전
시장 금액 예측 : 제품별(2017-2031년)
커넥티드 의료기기
용도
서비스
시장의 매력 : 제품별
제7장 세계 시장의 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과/발전
시장 금액 예측 : 최종사용자별(2017-2031년)
B2B
B2C
시장의 매력 : 최종사용자별
제8장 세계 시장의 분석과 예측 : 지역별
주요 조사 결과
시장 금액 예측 : 지역별(2017-2031년)
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 : 지역별
제9장 북미 시장 분석과 예측
제10장 유럽 시장 분석과 예측
제11장 아시아태평양 시장 분석과 예측
제12장 라틴아메리카 시장 분석과 예측
제13장 중동 및 아프리카 시장 분석과 예측
제14장 경쟁 구도
시장 기업 - 경쟁 매트릭스(계층별·기업 규모별)
시장 점유율 분석 : 기업별(2022년)
기업 개요
Dexcom, Inc.
Apple, Inc.
FitBit, Inc.
Withings
Proteus Digital Health, Inc.
Omada Health, Inc.
Welldoc, Inc.
Teladoc Health, Inc.
Noom, Inc.
Propeller Health.
Canary Health
BiogeniQ Inc.
Glooko, Inc.
Firstbeat Technologies
BioTelemetry, Inc.
KSA
영문 목차
영문목차
mHealth Market - Scope of Report
TMR's report on the global mHealth market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global mHealth market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global mHealth market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the mHealth market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global mHealth market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global mHealth market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global mHealth market.
The report delves into the competitive landscape of the global mHealth market. Key players operating in the global mHealth market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global mHealth market profiled in this report.
Key Questions Answered in Global mHealth market Report:
What is the sales/revenue generated by wearable injectors across all regions during the forecast period?
What are the opportunities in the global mHealth market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
mHealth Market - Research Objectives and Research Approach
The comprehensive report on the global mHealth market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global mHealth market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global mHealth market.
Table of Contents
1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global mHealth Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global mHealth Market Analysis and Forecasts, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. COVID-19 Pandemic Impact on Industry
6. mHealth Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017-2031
6.3.1. Connected Medical Devices
6.3.1.1. Heart Rate Monitors
6.3.1.2. Activity Monitors
6.3.1.3. Electrocardiograph
6.3.1.4. Fetal Monitoring
6.3.1.5. Neuromonitoring
6.3.1.6. Others
6.3.2. mHealth Applications
6.3.2.1. Fitness & Wellness
6.3.2.2. Diabetes
6.3.2.3. Cardiovascular Diseases
6.3.2.4. Central Nervous System Diseases
6.3.2.5. Respiratory Diseases
6.3.2.6. Musculoskeletal Diseases
6.3.2.7. Smoking Cessation
6.3.2.8. Medication Adherence
6.3.2.9. Others
6.3.3. mHealth Services
6.4. Market Attractiveness, by Product
7. Global mHealth Market Analysis and Forecast, by End-user
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. B2B
7.3.1.1. Patients
7.3.1.2. Caregivers
7.3.2. B2C
7.3.2.1. Providers
7.3.2.2. Payers
7.3.2.3. Employers
7.3.2.4. Others
7.4. Market Attractiveness, by End-user
8. Global mHealth Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017-2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Region
9. North America mHealth Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017-2031
9.2.1. Connected Medical Devices
9.2.1.1. Heart Rate Monitors
9.2.1.2. Activity Monitors
9.2.1.3. Electrocardiograph
9.2.1.4. Fetal Monitoring
9.2.1.5. Neuromonitoring
9.2.1.6. Others
9.2.2. mHealth Applications
9.2.2.1. Fitness & Wellness
9.2.2.2. Diabetes
9.2.2.3. Cardiovascular Diseases
9.2.2.4. Central Nervous System Diseases
9.2.2.5. Respiratory Diseases
9.2.2.6. Musculoskeletal Diseases
9.2.2.7. Smoking Cessation
9.2.2.8. Medication Adherence
9.2.2.9. Others
9.2.3. mHealth Services
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. B2B
9.3.1.1. Patients
9.3.1.2. Caregivers
9.3.2. B2C
9.3.2.1. Providers
9.3.2.2. Payers
9.3.2.3. Employers
9.3.2.4. Others
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe mHealth Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2031
10.2.1. Connected Medical Devices
10.2.1.1. Heart Rate Monitors
10.2.1.2. Activity Monitors
10.2.1.3. Electrocardiograph
10.2.1.4. Fetal Monitoring
10.2.1.5. Neuromonitoring
10.2.1.6. Others
10.2.2. mHealth Applications
10.2.2.1. Fitness & Wellness
10.2.2.2. Diabetes
10.2.2.3. Cardiovascular Diseases
10.2.2.4. Central Nervous System Diseases
10.2.2.5. Respiratory Diseases
10.2.2.6. Musculoskeletal Diseases
10.2.2.7. Smoking Cessation
10.2.2.8. Medication Adherence
10.2.2.9. Others
10.2.3. mHealth Services
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. B2B
10.3.1.1. Patients
10.3.1.2. Caregivers
10.3.2. B2C
10.3.2.1. Providers
10.3.2.2. Payers
10.3.2.3. Employers
10.3.2.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific mHealth Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
11.2.1. Connected Medical Devices
11.2.1.1. Heart Rate Monitors
11.2.1.2. Activity Monitors
11.2.1.3. Electrocardiograph
11.2.1.4. Fetal Monitoring
11.2.1.5. Neuromonitoring
11.2.1.6. Others
11.2.2. mHealth Applications
11.2.2.1. Fitness & Wellness
11.2.2.2. Diabetes
11.2.2.3. Cardiovascular Diseases
11.2.2.4. Central Nervous System Diseases
11.2.2.5. Respiratory Diseases
11.2.2.6. Musculoskeletal Diseases
11.2.2.7. Smoking Cessation
11.2.2.8. Medication Adherence
11.2.2.9. Others
11.2.3. mHealth Services
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. B2B
11.3.1.1. Patients
11.3.1.2. Caregivers
11.3.2. B2C
11.3.2.1. Providers
11.3.2.2. Payers
11.3.2.3. Employers
11.3.2.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America mHealth Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
12.2.1. Connected Medical Devices
12.2.1.1. Heart Rate Monitors
12.2.1.2. Activity Monitors
12.2.1.3. Electrocardiograph
12.2.1.4. Fetal Monitoring
12.2.1.5. Neuromonitoring
12.2.1.6. Others
12.2.2. mHealth Applications
12.2.2.1. Fitness & Wellness
12.2.2.2. Diabetes
12.2.2.3. Cardiovascular Diseases
12.2.2.4. Central Nervous System Diseases
12.2.2.5. Respiratory Diseases
12.2.2.6. Musculoskeletal Diseases
12.2.2.7. Smoking Cessation
12.2.2.8. Medication Adherence
12.2.2.9. Others
12.2.3. mHealth Services
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. B2B
12.3.1.1. Patients
12.3.1.2. Caregivers
12.3.2. B2C
12.3.2.1. Providers
12.3.2.2. Payers
12.3.2.3. Employers
12.3.2.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa mHealth Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
13.2.1. Connected Medical Devices
13.2.1.1. Heart Rate Monitors
13.2.1.2. Activity Monitors
13.2.1.3. Electrocardiograph
13.2.1.4. Fetal Monitoring
13.2.1.5. Neuromonitoring
13.2.1.6. Others
13.2.2. mHealth Applications
13.2.2.1. Fitness & Wellness
13.2.2.2. Diabetes
13.2.2.3. Cardiovascular Diseases
13.2.2.4. Central Nervous System Diseases
13.2.2.5. Respiratory Diseases
13.2.2.6. Musculoskeletal Diseases
13.2.2.7. Smoking Cessation
13.2.2.8. Medication Adherence
13.2.2.9. Others
13.2.3. mHealth Services
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. B2B
13.3.1.1. Patients
13.3.1.2. Caregivers
13.3.2. B2C
13.3.2.1. Providers
13.3.2.2. Payers
13.3.2.3. Employers
13.3.2.4. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Dexcom, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Apple, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. FitBit, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Withings
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Proteus Digital Health, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Omada Health, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Welldoc, Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Teladoc Health, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Noom, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Propeller Health.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Canary Health
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. BiogeniQ Inc.
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Portfolio
14.3.12.3. Financial Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. Glooko, Inc.
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Product Portfolio
14.3.13.3. Financial Overview
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
14.3.14. Firstbeat Technologies
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Product Portfolio
14.3.14.3. Financial Overview
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview
14.3.15. BioTelemetry, Inc.
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
